|
|
Volumn 7, Issue 10, 2006, Pages 785-
|
|
Reinvention
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
APOMORPHINE;
LEVODOPA;
RALOXIFENE;
RITUXIMAB;
TEMOZOLOMIDE;
THALIDOMIDE;
BREAST CANCER;
CANCER PATIENT;
CANCER RESEARCH;
CHRONIC LYMPHATIC LEUKEMIA;
DRUG APPROVAL;
DRUG LABELING;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG RESEARCH;
EDITORIAL;
ERECTILE DYSFUNCTION;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT REGULATION;
HEALTH CARE ORGANIZATION;
HEALTH PROGRAM;
HUMAN;
MEDICAL EDUCATION;
MORNING SICKNESS;
MULTIPLE MYELOMA;
MULTIPLE SCLEROSIS;
NONHODGKIN LYMPHOMA;
PARKINSON DISEASE;
POSTMENOPAUSE OSTEOPOROSIS;
PRIORITY JOURNAL;
SWEDEN;
UNITED KINGDOM;
UNITED STATES;
DOPAMINE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
NEOPLASMS;
TECHNOLOGY TRANSFER;
|
|
EID: 33749065535
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(06)70870-1 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|